{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"severe-neurodegenerative-syndrome-with-lipodystrophy","columns":[{"gene":"","key":"population-28c94c837d1fbbc148f9","label":"Encephalopathy, progressive, with or without lipodystrophy","mondoId":"MONDO:0014402","onsetQualifier":null,"originColumnKey":"MONDO:0014402/OMIM:615924","originalViews":[{"key":"MONDO:0014402/OMIM:615924","label":"Encephalopathy, progressive, with or without lipodystrophy","scopeLabel":"OMIM:615924","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["01fa52c586566a9481427a6b59c0e8c6e3311c5e5f821e590ec3a08a2e53de6b","0c63f7536026e50c5e77eaaae6105b39de010bd1bde996ce7d8088b8bf4107ec","142848fbd49c35f3ed7fd580b859f36162a9c4aca7451f1c7476da4c0dcfd470","287a31258a7cbeb999b2b274543f262e2a7f324b5d23d73a3737212733b1c288","2b7ffa3a8b4497195c751a24eeb3bd2388e0577207650c81b2cad1bdaca2966b","40df159a948bfcde9a93c492181919a50fb2d9cb97b50be8275a02ae4b37b7a7","42d06252aef4cdda1a39e7706cd142e35532ad3871849a32ae8645b7c74bd345","4e64d9ec64aac35e3999c406d1af1a78f13fbf0b2f670dbb3c52277771501e09","5564e806ed537aa9cac19a401c8c7ae2694f37706913b9508aad64f8238a67fc","8b596fe2a120ccde89617ed77b7df850525acc0b2c98167f230045d939a58d07","94dfc3100fcf3e9175cb713161c1337dfdd82b00d8f5805cc3d41865cc7660e8","9ba2d7f0dabb4c3d4f7dffa97fa36dc8e5e66b03a6190bfa3d24f5aa67b2252b","a277216c09df85c90bbd15d3c802fcd4792cd43c3f2f2562acff2e6f0b996508","ab90cd6356b7b7909826272e384f54d3163bbcdca32c31b4af62c0ef049366b1","b84d624debe5881f52bfa47424262c0180c03b860f14bd1fbf11d2df3c7a790a","c88e93b3ace703b552505233f6ea18c6d052dea2d75f891065b70c33c79154c4","e0be959d8c98d227e46daf0544bdb590f18fa3f82b26b85eaba40a31c19c0da9","ed5f26f7094fa2b806c840c7241ae00c19d4e78b3953b96abad57607ba794aa0","f417b05b6b60fa054c8cefbcb603578de05c90e98b6d0153f988ff4fd3de42e7"],"recordQualifiers":{},"scopeLabel":"OMIM:615924","sourceIds":["OMIM:615924"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-8efce80b3027ca65374a","label":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","mondoId":"MONDO:0014402","onsetQualifier":null,"originColumnKey":"MONDO:0014402/ORPHA:363400","originalViews":[{"key":"MONDO:0014402/ORPHA:363400","label":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","scopeLabel":"ORPHA:363400","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0787a00787b78b2fd69d7fdb6a5efc56854947a0314d54445ac5090b9f67c2f3","114485fed5f66b54e50501d0eb1dea7bba7348675d0ef083f6a4f81c894d6f7a","1b0e7914caa5452b76f1d2b587b08a3602256868ed070bb81d0c141af052e94a","25a5049af01f93242203c8412a7aba74ba8dcfa72688379aecc99650753c33c8","367036242c53fdc485d3c3714c760cc6d7c18402361e8f3b24e0b5800a02d3c7","3dceef50b33510a3c9caa19ce91afd8ef16c95b3b7f41227406d04e5c174dd0a","43e42a0f3a77ba0ddf4f1808658ad1968849d3f0b4ce5f633c379eb20d946d79","4ece4227d6f6702d2387f847569ed71c790f1fadc8680077125f8b063606785c","50120da667727bc43945e09731ad17ffad50055d5aef18bdc73418218a048d0d","58776ff95f4ba47bf9a09657cad86607230c47a587228beeae40d29e37fe3ecf","593c9ba1beb7149606c1158018413b35aebdd9e07a9e931fe1a3f4b00dedb8d5","5ef45e6af3679d3ff5cadd434b9c1d9c0fd50e7a75760f68a244a533196e8c13","63c0347f635df76f6ce272b6b93f758f2c252695c21b0117593f9c8ad5b9be44","651207082475fc50deeba24703e569509ac65f154a986491c1666f6dd26dd68d","702cad7762fd839ea9fde04c52781e714f9f9329e0b429d6af5c18356f60f2e2","733180ec6bdda9f92b4911733a5fd4a6b4f57cd91a49ba1ecec07be5c831f8cb","761ecfc9239f12e5c85d01b1c6296aa3fe24bc2edd118edd8ded713e3f1f4e1f","795939cbfbc0c79fa4314a946b55345afe8406f0765dc81949007041e4790a0c","837a9b8214a4411651e5a1a0c79d9bf3d03fb5b5d807106c970e275bd60ced04","936b93528ea679c2553a692068cabac2106f9182f79d4cf91055ebad5872cc5e","95290820bc83f36182b6b216b5b8ef7e852b404029d719fba409fde18b0ba8f6","96dfdee50b0c61241dce4320089eb07f6d769384e48749124f44a8a5851378e5","98ca60c71417b57c58a2cc173e1f9522dbb6432bc6c5c4b177b1f1fcd3c53e20","9c3997f0d4132d23aa8c892b410913f51757f55a72fea50ae72591dd5b7514c9","a3fbf4d18f32f53a99e355a8173ad493023b018fefa6cc0ddaff19cdd01e08fb","b6bb70d97f01fd3c782fd46e9dc6ae3a79adee2a5ad73b7e05263c74feb56d91","be2e24fcdeb32f40038445a9ecc121ab5167fe7390f3981c9a7a0ff3069168fd","cbf12edcfadf016203f3c0dc8e30c9e1e84fd53ff2648917e6ec59a65c878bc9","d3e54c23b464ca32f6a82a094b00fda19aa324624ed8fb03bb2f91ef73f94cf4","d47889fb48216453a40d97fd2f1e9e9977556f9e943600642b4b5842c94d716d","de6323541b492e8e8a096c4c0605e465e087a3cd70c10d8afe96f6044f898e9a","df0bbfeb511e669a3b709e2132cb5ec24abb2108c3c75fc1b4f8aa529b57ccf5","e2348f395213e8a56e4bcf7e0e3409288ae354e308ac81902e9e5a8f4ebf4edd","e5c50dc8d0914634bef9ed052d0eb1e8c031dc3841ad6d199e9f909f598182dd","e92b287d048f963e6b33c859c250f632b62548858f9be17570120035c7a15c5c","ea9136becff89fde08c5b5c42973017a620def50907f043ac59347be60bb11f2","eb70bd72bcb7c38455bd2e4d7055012e089dd4753a6d500f6245b0c6dd543c3e"],"recordQualifiers":{},"scopeLabel":"ORPHA:363400","sourceIds":["ORPHA:363400"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-28c94c837d1fbbc148f9","population-8efce80b3027ca65374a"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0007256","HP:0000956","HP:0001251","HP:0001348","HP:0002340","HP:0002059","HP:0001394"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":56,"sourceGroups":{"omim":19,"orphanet":37}},"features":[{"hpoId":"HP:0007256","label":"Abnormal pyramidal sign","primary":true},{"hpoId":"HP:0000956","label":"Acanthosis nigricans","primary":true},{"hpoId":"HP:0001251","label":"Ataxia","primary":true},{"hpoId":"HP:0001348","label":"Brisk reflexes","primary":true},{"hpoId":"HP:0002340","label":"Caudate atrophy","primary":true},{"hpoId":"HP:0002059","label":"Cerebral atrophy","primary":true},{"hpoId":"HP:0001394","label":"Cirrhosis","primary":true},{"hpoId":"HP:0000280","label":"Coarse facial features","primary":false},{"hpoId":"HP:0100543","label":"Cognitive impairment","primary":false},{"hpoId":"HP:0000750","label":"Delayed speech and language development","primary":false},{"hpoId":"HP:0002376","label":"Developmental regression","primary":false},{"hpoId":"HP:0001332","label":"Dystonia","primary":false},{"hpoId":"HP:0001298","label":"Encephalopathy","primary":false},{"hpoId":"HP:0002066","label":"Gait ataxia","primary":false},{"hpoId":"HP:0002230","label":"Generalized hirsutism","primary":false},{"hpoId":"HP:0009064","label":"Generalized lipodystrophy","primary":false},{"hpoId":"HP:0001397","label":"Hepatic steatosis","primary":false},{"hpoId":"HP:0002240","label":"Hepatomegaly","primary":false},{"hpoId":"HP:0000752","label":"Hyperactivity","primary":false},{"hpoId":"HP:0000842","label":"Hyperinsulinemia","primary":false},{"hpoId":"HP:0001347","label":"Hyperreflexia","primary":false},{"hpoId":"HP:0000822","label":"Hypertension","primary":false},{"hpoId":"HP:0002155","label":"Hypertriglyceridemia","primary":false},{"hpoId":"HP:0002311","label":"Incoordination","primary":false},{"hpoId":"HP:0000855","label":"Insulin resistance","primary":false},{"hpoId":"HP:0002451","label":"Limb dystonia","primary":false},{"hpoId":"HP:0002371","label":"Loss of speech","primary":false},{"hpoId":"HP:0001268","label":"Mental deterioration","primary":false},{"hpoId":"HP:0001336","label":"Myoclonus","primary":false},{"hpoId":"HP:0003198","label":"Myopathy","primary":false},{"hpoId":"HP:0002529","label":"Neuronal loss in central nervous system","primary":false},{"hpoId":"HP:0002448","label":"Progressive encephalopathy","primary":false},{"hpoId":"HP:0007272","label":"Progressive psychomotor deterioration","primary":false},{"hpoId":"HP:0025128","label":"Reduced intraabdominal adipose tissue","primary":false},{"hpoId":"HP:0003758","label":"Reduced subcutaneous adipose tissue","primary":false},{"hpoId":"HP:0002878","label":"Respiratory failure","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0002360","label":"Sleep disturbance","primary":false},{"hpoId":"HP:0001257","label":"Spasticity","primary":false},{"hpoId":"HP:0002133","label":"Status epilepticus","primary":false},{"hpoId":"HP:0002273","label":"Tetraparesis","primary":false},{"hpoId":"HP:0001337","label":"Tremor","primary":false}],"ledeHtml":"A rare, genetic, neurodegenerative disorder characterized by progressive psychomotor and cognitive regression (manifesting with gait ataxia, spasticity, loss of language, mild to severe intellectual disability, pyramidal and extrapyramidal signs and, frequently, development of tretraplegia or tetraparesis) associated with variable degrees of lipodystrophy, hepatomegaly, hypertriglyceridemia and muscular hypertrophy. Hyperactivity, tremor and development of seizures may also be associated.","mondoId":"MONDO:0014402","node":{"canonicalSlug":"severe-neurodegenerative-syndrome-with-lipodystrophy","comparisons":[{"documentSha256":"18e14a553205faab9b1e3069e1636c76f8da66f0aa2eb43213dd53e31572ef38","key":"legacy-severe-neurodegenerative-syndrome-with-lipodystrophy","kind":"legacy","label":"severe neurodegenerative syndrome with lipodystrophy","memberIds":["MONDO:0014402"],"mondoId":"MONDO:0014402","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/severe-neurodegenerative-syndrome-with-lipodystrophy.18e14a553205faab9b1e3069e1636c76f8da66f0aa2eb43213dd53e31572ef38.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Severe neurodegenerative syndrome with lipodystrophy","originalSourceId":"ORPHA:363400","paragraphs":["A rare, genetic, neurodegenerative disorder characterized by progressive psychomotor and cognitive regression (manifesting with gait ataxia, spasticity, loss of language, mild to severe intellectual disability, pyramidal and extrapyramidal signs and, frequently, development of tretraplegia or tetraparesis) associated with variable degrees of lipodystrophy, hepatomegaly, hypertriglyceridemia and muscular hypertrophy. Hyperactivity, tremor and development of seizures may also be associated."],"rawAttribution":"ORPHA:363400","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:02:37Z","upstream":"ORPHA:363400","url":"https://rarediseases.info.nih.gov/diseases/17552"},"ownColumnKeys":["population-28c94c837d1fbbc148f9","population-8efce80b3027ca65374a"],"publication":"published","relationships":[{"kind":"parent","label":"hereditary lipodystrophy","mondoId":"MONDO:0020087","slug":"hereditary-lipodystrophy"},{"kind":"parent","label":"inherited neurodegenerative disorder","mondoId":"MONDO:0024237","slug":"inherited-neurodegenerative-disorder"},{"kind":"parent","label":"Mendelian encephalopathy","mondoId":"MONDO:0100198","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"01fa52c586566a9481427a6b59c0e8c6e3311c5e5f821e590ec3a08a2e53de6b","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615924","disease_name":"Encephalopathy, progressive, with or without lipodystrophy","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"OMIM:615924","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"0787a00787b78b2fd69d7fdb6a5efc56854947a0314d54445ac5090b9f67c2f3","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002311","is_excluded":false,"label":"Incoordination","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"0c63f7536026e50c5e77eaaae6105b39de010bd1bde996ce7d8088b8bf4107ec","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615924","disease_name":"Encephalopathy, progressive, with or without lipodystrophy","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000752","is_excluded":false,"label":"Hyperactivity","onset_id":null,"reference":"OMIM:615924","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"114485fed5f66b54e50501d0eb1dea7bba7348675d0ef083f6a4f81c894d6f7a","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000280","is_excluded":false,"label":"Coarse facial features","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"142848fbd49c35f3ed7fd580b859f36162a9c4aca7451f1c7476da4c0dcfd470","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615924","disease_name":"Encephalopathy, progressive, with or without lipodystrophy","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"OMIM:615924","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"1b0e7914caa5452b76f1d2b587b08a3602256868ed070bb81d0c141af052e94a","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002230","is_excluded":false,"label":"Generalized hirsutism","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"25a5049af01f93242203c8412a7aba74ba8dcfa72688379aecc99650753c33c8","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001394","is_excluded":false,"label":"Cirrhosis","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"287a31258a7cbeb999b2b274543f262e2a7f324b5d23d73a3737212733b1c288","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615924","disease_name":"Encephalopathy, progressive, with or without lipodystrophy","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001257","is_excluded":false,"label":"Spasticity","onset_id":null,"reference":"OMIM:615924","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"2b7ffa3a8b4497195c751a24eeb3bd2388e0577207650c81b2cad1bdaca2966b","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615924","disease_name":"Encephalopathy, progressive, with or without lipodystrophy","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0007256","is_excluded":false,"label":"Abnormal pyramidal sign","onset_id":null,"reference":"OMIM:615924","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"367036242c53fdc485d3c3714c760cc6d7c18402361e8f3b24e0b5800a02d3c7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001347","is_excluded":false,"label":"Hyperreflexia","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3dceef50b33510a3c9caa19ce91afd8ef16c95b3b7f41227406d04e5c174dd0a","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0025128","is_excluded":false,"label":"Reduced intraabdominal adipose tissue","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"40df159a948bfcde9a93c492181919a50fb2d9cb97b50be8275a02ae4b37b7a7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615924","disease_name":"Encephalopathy, progressive, with or without lipodystrophy","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002273","is_excluded":false,"label":"Tetraparesis","onset_id":null,"reference":"OMIM:615924","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"42d06252aef4cdda1a39e7706cd142e35532ad3871849a32ae8645b7c74bd345","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615924","disease_name":"Encephalopathy, progressive, with or without lipodystrophy","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000750","is_excluded":false,"label":"Delayed speech and language development","onset_id":null,"reference":"OMIM:615924","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"43e42a0f3a77ba0ddf4f1808658ad1968849d3f0b4ce5f633c379eb20d946d79","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002066","is_excluded":false,"label":"Gait ataxia","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"4e64d9ec64aac35e3999c406d1af1a78f13fbf0b2f670dbb3c52277771501e09","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615924","disease_name":"Encephalopathy, progressive, with or without lipodystrophy","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001336","is_excluded":false,"label":"Myoclonus","onset_id":null,"reference":"OMIM:615924","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"4ece4227d6f6702d2387f847569ed71c790f1fadc8680077125f8b063606785c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0002133","is_excluded":false,"label":"Status epilepticus","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"50120da667727bc43945e09731ad17ffad50055d5aef18bdc73418218a048d0d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0002448","is_excluded":false,"label":"Progressive encephalopathy","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"5564e806ed537aa9cac19a401c8c7ae2694f37706913b9508aad64f8238a67fc","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615924","disease_name":"Encephalopathy, progressive, with or without lipodystrophy","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002376","is_excluded":false,"label":"Developmental regression","onset_id":null,"reference":"OMIM:615924","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"58776ff95f4ba47bf9a09657cad86607230c47a587228beeae40d29e37fe3ecf","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0100543","is_excluded":false,"label":"Cognitive impairment","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"593c9ba1beb7149606c1158018413b35aebdd9e07a9e931fe1a3f4b00dedb8d5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002451","is_excluded":false,"label":"Limb dystonia","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5ef45e6af3679d3ff5cadd434b9c1d9c0fd50e7a75760f68a244a533196e8c13","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000842","is_excluded":false,"label":"Hyperinsulinemia","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"63c0347f635df76f6ce272b6b93f758f2c252695c21b0117593f9c8ad5b9be44","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000752","is_excluded":false,"label":"Hyperactivity","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"651207082475fc50deeba24703e569509ac65f154a986491c1666f6dd26dd68d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001337","is_excluded":false,"label":"Tremor","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"702cad7762fd839ea9fde04c52781e714f9f9329e0b429d6af5c18356f60f2e2","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"733180ec6bdda9f92b4911733a5fd4a6b4f57cd91a49ba1ecec07be5c831f8cb","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002529","is_excluded":false,"label":"Neuronal loss in central nervous system","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"761ecfc9239f12e5c85d01b1c6296aa3fe24bc2edd118edd8ded713e3f1f4e1f","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0009064","is_excluded":false,"label":"Generalized lipodystrophy","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"795939cbfbc0c79fa4314a946b55345afe8406f0765dc81949007041e4790a0c","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002240","is_excluded":false,"label":"Hepatomegaly","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"837a9b8214a4411651e5a1a0c79d9bf3d03fb5b5d807106c970e275bd60ced04","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000855","is_excluded":false,"label":"Insulin resistance","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"8b596fe2a120ccde89617ed77b7df850525acc0b2c98167f230045d939a58d07","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615924","disease_name":"Encephalopathy, progressive, with or without lipodystrophy","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001298","is_excluded":false,"label":"Encephalopathy","onset_id":null,"reference":"OMIM:615924","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"936b93528ea679c2553a692068cabac2106f9182f79d4cf91055ebad5872cc5e","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000822","is_excluded":false,"label":"Hypertension","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"94dfc3100fcf3e9175cb713161c1337dfdd82b00d8f5805cc3d41865cc7660e8","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615924","disease_name":"Encephalopathy, progressive, with or without lipodystrophy","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002529","is_excluded":false,"label":"Neuronal loss in central nervous system","onset_id":null,"reference":"OMIM:615924","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"95290820bc83f36182b6b216b5b8ef7e852b404029d719fba409fde18b0ba8f6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002059","is_excluded":false,"label":"Cerebral atrophy","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"96dfdee50b0c61241dce4320089eb07f6d769384e48749124f44a8a5851378e5","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000956","is_excluded":false,"label":"Acanthosis nigricans","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"98ca60c71417b57c58a2cc173e1f9522dbb6432bc6c5c4b177b1f1fcd3c53e20","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007256","is_excluded":false,"label":"Abnormal pyramidal sign","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"9ba2d7f0dabb4c3d4f7dffa97fa36dc8e5e66b03a6190bfa3d24f5aa67b2252b","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615924","disease_name":"Encephalopathy, progressive, with or without lipodystrophy","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001337","is_excluded":false,"label":"Tremor","onset_id":null,"reference":"OMIM:615924","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"9c3997f0d4132d23aa8c892b410913f51757f55a72fea50ae72591dd5b7514c9","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002878","is_excluded":false,"label":"Respiratory failure","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"a277216c09df85c90bbd15d3c802fcd4792cd43c3f2f2562acff2e6f0b996508","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615924","disease_name":"Encephalopathy, progressive, with or without lipodystrophy","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001332","is_excluded":false,"label":"Dystonia","onset_id":null,"reference":"OMIM:615924","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"a3fbf4d18f32f53a99e355a8173ad493023b018fefa6cc0ddaff19cdd01e08fb","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"ab90cd6356b7b7909826272e384f54d3163bbcdca32c31b4af62c0ef049366b1","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615924","disease_name":"Encephalopathy, progressive, with or without lipodystrophy","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001347","is_excluded":false,"label":"Hyperreflexia","onset_id":null,"reference":"OMIM:615924","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"b6bb70d97f01fd3c782fd46e9dc6ae3a79adee2a5ad73b7e05263c74feb56d91","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001257","is_excluded":false,"label":"Spasticity","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b84d624debe5881f52bfa47424262c0180c03b860f14bd1fbf11d2df3c7a790a","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:615924","disease_name":"Encephalopathy, progressive, with or without lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002155","is_excluded":false,"label":"Hypertriglyceridemia","onset_id":null,"reference":"OMIM:615924","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"be2e24fcdeb32f40038445a9ecc121ab5167fe7390f3981c9a7a0ff3069168fd","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003758","is_excluded":false,"label":"Reduced subcutaneous adipose tissue","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"c88e93b3ace703b552505233f6ea18c6d052dea2d75f891065b70c33c79154c4","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615924","disease_name":"Encephalopathy, progressive, with or without lipodystrophy","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002371","is_excluded":false,"label":"Loss of speech","onset_id":null,"reference":"OMIM:615924","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"cbf12edcfadf016203f3c0dc8e30c9e1e84fd53ff2648917e6ec59a65c878bc9","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0007272","is_excluded":false,"label":"Progressive psychomotor deterioration","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d3e54c23b464ca32f6a82a094b00fda19aa324624ed8fb03bb2f91ef73f94cf4","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001336","is_excluded":false,"label":"Myoclonus","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d47889fb48216453a40d97fd2f1e9e9977556f9e943600642b4b5842c94d716d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002360","is_excluded":false,"label":"Sleep disturbance","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"de6323541b492e8e8a096c4c0605e465e087a3cd70c10d8afe96f6044f898e9a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001348","is_excluded":false,"label":"Brisk reflexes","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"df0bbfeb511e669a3b709e2132cb5ec24abb2108c3c75fc1b4f8aa529b57ccf5","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003198","is_excluded":false,"label":"Myopathy","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"e0be959d8c98d227e46daf0544bdb590f18fa3f82b26b85eaba40a31c19c0da9","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615924","disease_name":"Encephalopathy, progressive, with or without lipodystrophy","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002059","is_excluded":false,"label":"Cerebral atrophy","onset_id":null,"reference":"OMIM:615924","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"e2348f395213e8a56e4bcf7e0e3409288ae354e308ac81902e9e5a8f4ebf4edd","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002155","is_excluded":false,"label":"Hypertriglyceridemia","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e5c50dc8d0914634bef9ed052d0eb1e8c031dc3841ad6d199e9f909f598182dd","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002340","is_excluded":false,"label":"Caudate atrophy","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e92b287d048f963e6b33c859c250f632b62548858f9be17570120035c7a15c5c","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001397","is_excluded":false,"label":"Hepatic steatosis","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ea9136becff89fde08c5b5c42973017a620def50907f043ac59347be60bb11f2","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000750","is_excluded":false,"label":"Delayed speech and language development","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"eb70bd72bcb7c38455bd2e4d7055012e089dd4753a6d500f6245b0c6dd543c3e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363400","disease_name":"Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002273","is_excluded":false,"label":"Tetraparesis","onset_id":null,"reference":"ORPHA:363400","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"ed5f26f7094fa2b806c840c7241ae00c19d4e78b3953b96abad57607ba794aa0","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615924","disease_name":"Encephalopathy, progressive, with or without lipodystrophy","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001268","is_excluded":false,"label":"Mental deterioration","onset_id":null,"reference":"OMIM:615924","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"f417b05b6b60fa054c8cefbcb603578de05c90e98b6d0153f988ff4fd3de42e7","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:615924","disease_name":"Encephalopathy, progressive, with or without lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002240","is_excluded":false,"label":"Hepatomegaly","onset_id":null,"reference":"OMIM:615924","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17552\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:363400</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare, genetic, neurodegenerative disorder characterized by progressive psychomotor and cognitive regression (manifesting with gait ataxia, spasticity, loss of language, mild to severe intellectual disability, pyramidal and extrapyramidal signs and, frequently, development of tretraplegia or tetraparesis) associated with variable degrees of lipodystrophy, hepatomegaly, hypertriglyceridemia and muscular hypertrophy. Hyperactivity, tremor and development of seizures may also be associated.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17552\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"severe-neurodegenerative-syndrome-with-lipodystrophy","sourceDocuments":[{"name":"GARD: Severe neurodegenerative syndrome with lipodystrophy","reviewed":null,"source_release":"2026-10-21T17:02:37Z","url":"https://rarediseases.info.nih.gov/diseases/17552"}],"sourceNote":"","synonyms":["encephalopathy, progressive, with or without lipodystrophy","PELD","severe neurodegenerative syndrome due to BSCL2 deficiency"],"takeawayHtml":"","title":"severe neurodegenerative syndrome with lipodystrophy"},"schemaVersion":1}
